Rights and permissions
About this article
Cite this article
Everolimus cost effective for mRCC after sunitinib failure. Pharmacoecon. Outcomes News 640, 5 (2011). https://doi.org/10.2165/00151234-201106400-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106400-00014